5/6/2025CStone Unveils Promising Preclinical Data for Trispecific Antibody CS2...

5/6/2025Kintor Reports Superior Hair Regrowth Results for KX-826 and Minoxidil...

5/6/2025China Approves Six Novel Drugs in April 2025, Marking Significant Adva...

5/6/2025Immunochina’s IM96 CAR-T Cell Therapy Wins FDA IND Clearance

5/5/2025China Introduces A New Regulatory Data Protection And Exclusivity Mech...

5/2/2025Recent Executive Moves

5/1/2025AstraZeneca Faces Escalating Legal Challenges in China Over Drug Impor...

5/1/2025CSL Reviews Potential China Tariff Relief for U.S.-Produced Albumin

5/1/2025China Accelerates Investment in Africa's Burgeoning Pharma Sector

5/1/2025D3 Bio Showcases Promising Next-Gen KRAS G12C Inhibitor at AACR and in...

5/1/2025Pharma's Crossroads: U.S. Investment Surges Under Trump, While China F...

4/30/2025BeiGene Secures Key Patent Victory in Brukinsa Dispute with AbbVie's P...

4/30/2025Escugen and ConjugateBio Announce Exclusive Option Agreement for EZWi-...

4/30/2025Sandoz and Henlius Collaborate to Broaden Oncology Treatment Options

4/29/2025Akeso's BsAb Shows Promising Survival Benefit in Lung Cancer Trial

4/29/2025Qyuns Sets Up Newco for Global Rights to Its Novel Long-Acting BsAb QX...

4/29/2025DualityBio and AstraZeneca Unite to Investigate Novel Lung Cancer Comb...

4/29/2025Innovent Initiates Global Phase 1 Trial for ADC IBI3020

4/29/20253SBio Advances Novel MUC17-Targeting Therapy SSS59 into Global Phase 1...

4/29/2025PegBio Poised for IPO on Hong Kong Stock Exchange Following Successful...

4/29/2025Ribo Life Science Files for IPO on HKSE, Backed by CICC and Citi

4/29/2025CentyMed's Novel EGFR/CD3 BsAb CMDE005 Receives FDA Green Light for Cl...

4/29/2025XellSmart Receives NMPA Approval for Landmark Trial of "On-Demand" iP...

4/29/2025JW and Juno Forge sLVV Licensing Agreement to Advance Cell Therapy Man...

4/29/2025Frontera's Gene Therapy FT-017 Achieves Dual Regulatory Clearance in U...

4/29/2025China's Hospital Drug Market Shows Slight Growth in 2024, Driven by On...

4/29/2025China NMPA Suspends Digoxin API Imports from VITAL LABS

4/29/2025Hengrui Secures Approval for Hong Kong IPO

4/29/2025InnoCare's Orelabrutinib Receives NMPA Approval as First-Line Therapy ...

4/29/2025Innovent Announces NMPA Approval of Limertinib

Page:38/801 Total number of articles:24010: [First][<<] [36] [37] [38] [39] [40] [>>] [End]